LobbyingNephcure lobbying by quarter
Nephcure's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q1 2024.
Nephcure
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q1 2024
- The first quarter a report named it
Lobbying by quarter
No lobbying spend in this period.
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2024 | $0 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
No issue reported.
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
No house or agency named.
Firms it paid
| Firm | ||
|---|---|---|
| In-houseNephcure | $0 | 10 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/03for Q2 | In-house | Under $5,000 |
| 05/04for Q1 | In-house | Under $5,000 |
| 02/05for Q4 2025 | In-house | Under $5,000 |
| 25/11/17for Q3 2025 | In-house | Under $5,000 |
| 25/08/05for Q2 2025 | In-house | Under $5,000 |
| 25/08/05for Q2 2025 | In-house | Under $5,000 |
| 25/05/05for Q1 2025 | In-house | Under $5,000 |
| 25/02/04for Q4 2024 | In-house | Under $5,000 |
| 24/11/05for Q3 2024 | In-house | Under $5,000 |
| 24/08/06for Q2 2024 | In-house | Under $5,000 |
| 24/04/09for Q1 2024 | In-house | Under $5,000 |
| 24/04/09for Q1 2024 | In-house | Under $5,000 |